investorscraft@gmail.com

Stock Analysis & ValuationGeneDx Holdings Corp. (WGSWW)

Professional Stock Screener
Previous Close
$0.01
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)131.722124416
Intrinsic value (DCF)1.1017642
Graham-Dodd Method7.05113594
Graham Formulan/a

Company Information

North Tower
Stamford, DE 06902
United States
Phone: 888 729 1206
Industry: Medical - Healthcare Information Services
Sector: Healthcare
CEO: Katherine A. Stueland
Full Time Employees: 1000

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

HomeMenuAccount